Search | TVST | ARVO Journals

Showing 1 – 20 of 112

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retina December 2018

A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3

PDF

Mark M. Hassall; Alun R. Barnard; Harry O. Orlans; Michelle E. McClements; Peter Charbel Issa; Sher A. Aslam; Robert E. MacLaren
TAGS: mice, retinal cone, mutation, electroretinography, achromatopsia
Invest. Ophthalmol. Vis. Sci.. 2018; 59(15):6102-6110. doi: 10.1167/iovs.18-24328

ARVO Annual Meeting Abstract July 2018

Validation of Staphylococcus aureus Cas9 gRNAs targeting EGFP present in the rod cells of the Nrl-EGFP mouse line.

Caroline Peddle; Robert E MacLaren; Michelle McClements

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):382. doi:

ARVO Annual Meeting Abstract July 2018

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Robert E MacLaren; Kanmin Xue; Alun R Barnard; Maria In?s Patrício; Thomas L Edwards; Susan Downes; Andrew Lotery; Graeme Black; Andrew Webster; Jasleen K Jolly; Miguel C Seabra

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1195. doi:

ARVO Annual Meeting Abstract July 2018

Assessment of adjunctive gene therapy to dormant cones in end-stage retinitis pigmentosa

Mark Hassall; Michelle McClements; Alun R Barnard; Sher A Aslam; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):989. doi:

ARVO Annual Meeting Abstract July 2018

The central foveal thickness is similar to age-matched controls in early stage choroideremia.

Kirti Madhukar Jasani; Kanmin Xue; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1530. doi:

ARVO Annual Meeting Abstract July 2018

Olfactory dysfunction in patients with CNGB1 -related retinitis pigmentosa

Peter Charbel Issa; Peggy Reuter; Laura Kuehlewein; Johannes Birtel; Martin Gliem; Anke Tropitzsch; Katherine Whitcroft; Hanno Bolz; Kenji Ishihara; Robert E MacLaren; Susan Downes; Akio Oishi; Eberhart Zrenner; Susanne Kohl; Thomas Hummel

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1565. doi:

ARVO Annual Meeting Abstract July 2018

Beyond the average threshold: Alternatives in the analysis of microperimetry data

Iain Robert Wilson; Jasleen Jolly; Susan Downes; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1698. doi:

ARVO Annual Meeting Abstract July 2018

An unusual presentation of choroideremia with macular dystrophy associated with early visual acuity loss

Georgios Kontos; Jennifer Kwan; Robert E MacLaren; Susan Downes

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5387. doi:

ARVO Annual Meeting Abstract July 2018

Usher genes; from a clinical and genetic perspective

Helena Margaret Anthonia Feenstra; Mital Shah; Morag Shanks; Robert E MacLaren; Penny Clouston; Susan Downes

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):2341. doi:

ARVO Annual Meeting Abstract July 2018

Chimeric human opsins as optogenetic light sensitizers

Doron Hickey; Wayne IL Davies; Steven Hughes; Jessica Rodgers; Navamayooran Thavanesan; Robert E MacLaren; Mark W Hankins

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5989. doi:

ARVO Annual Meeting Abstract July 2018

The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Mark E Pennesi; Byron L Lam; M Dominik Fischer; Eeva-Marja Kaarina Sankila; Frank G. Holz; Robert E MacLaren; David G Birch; Ian M MacDonald; Graeme Black; Carel C B Hoyng; Neil M Bressler; Stephen H. Tsang; Kimberly E Stepien; Michael S Ip; Vedran Pavlovic; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3898. doi:

ARVO Annual Meeting Abstract July 2018

Spatial distribution of preserved autofluorescence in patients with choroideremia

Amir H Hariri; Aniz Girach; Michael S Ip; Byron L Lam; M Dominik Fischer; Eeva-Marja Kaarina Sankila; Mark E Pennesi; Frank G. Holz; David G Birch; Robert E MacLaren; Ian M MacDonald; Carel C B Hoyng; Graeme Black; Neil M Bressler; Stephen H. Tsang; Srinivas R. Sadda

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4991. doi:

ARVO Annual Meeting Abstract July 2018

A first-in-man trial assessing robotic surgery inside the human eye to perform a subretinal injection

Thomas L Edwards; Kanmin Xue; Thijs Meenink; Maarten Beelen; Gerrit Naus; Matthew P Simunovic; Marta Latasiewicz; Andrew Farmery; Marc D De Smet; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):5936. doi:

ARVO Annual Meeting Abstract July 2018

Hydroxychloroquine enhances the efficacy of retinal gene therapy

Laurel Clare Chandler; Alun R Barnard; Maria In?s Patrício; Kanmin Xue; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6005. doi:

ARVO Annual Meeting Abstract July 2018

Retinal degeneration in choroideremia follows an exponential decay function

James William Aylward; Kanmin Xue; Maria In?s Patrício; Jasleen K Jolly; Jonathan Charles Wood; Jonathan Brett; Kirti Jasani; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):6060. doi:

ARVO Annual Meeting Abstract July 2018

An optimized AAV vector for rod-specific gene expression

Harry Otway Orlans; Michelle McClements; Maria In?s Patrício; Alun R Barnard; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4534. doi:

ARVO Annual Meeting Abstract July 2018

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Laura Kuehlewein; Nicole Troelenberg; Krunoslav Stingl; Sebastian Schleehauf; Akos Kusnyerik; Helmut Sachs; Johann Roider; Timothy L Jackson; Robert E MacLaren; Caroline Chee; Barbara Wilhelm; Florian Gekeler; Karl Ulrich Bartz-Schmidt; Eberhart Zrenner; Katarina Stingl

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4561. doi:

ARVO Annual Meeting Abstract July 2018

Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Byron L Lam; M Dominik Fischer; Mark E Pennesi; Eeva-Marja Kaarina Sankila; Frank G. Holz; Robert E MacLaren; David G Birch; Ian M MacDonald; Carel C B Hoyng; Graeme Black; Neil M Bressler; Stephen H. Tsang; Kimberly E Stepien; Michael S Ip; Vedran Pavlovic; Aniz Girach

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3899. doi:

ARVO Annual Meeting Abstract July 2018

Pathological donor splice site mutations beyond the dinucleotide canonical sequence in choroideremia

Lewis Fry; Maria In?s Patrício; Jonathan Williams; Penny Clouston; Kanmin Xue; Alun R Barnard; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3493. doi:

ARVO Annual Meeting Abstract July 2018

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

Celine-Lea Halioua-Haubold; Jasleen Jolly; Rafael Pinedo Villanueva; David Brindley; Robert E MacLaren

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3897. doi:

1 2 3 4 5

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Filters

Specify Date Range

A Novel Achromatopsia Mouse Model Resulting From a Naturally Occurring Missense Change in Cngb3

Validation of Staphylococcus aureus Cas9 gRNAs targeting EGFP present in the rod cells of the Nrl-EGFP mouse line.

Retinal Gene Therapy for Choroideremia in a Multicenter Dose Escalation Phase I/II Clinical Trial

Assessment of adjunctive gene therapy to dormant cones in end-stage retinitis pigmentosa

The central foveal thickness is similar to age-matched controls in early stage choroideremia.

Olfactory dysfunction in patients with CNGB1 -related retinitis pigmentosa

Beyond the average threshold: Alternatives in the analysis of microperimetry data

An unusual presentation of choroideremia with macular dystrophy associated with early visual acuity loss

Usher genes; from a clinical and genetic perspective

Chimeric human opsins as optogenetic light sensitizers

The Natural History of the Progression of Choroideremia (NIGHT) Study: Longitudinal Changes in Visual Acuity over 12 Months

Spatial distribution of preserved autofluorescence in patients with choroideremia

A first-in-man trial assessing robotic surgery inside the human eye to perform a subretinal injection

Hydroxychloroquine enhances the efficacy of retinal gene therapy

Retinal degeneration in choroideremia follows an exponential decay function

An optimized AAV vector for rod-specific gene expression

Changes in Microchip Position after Implantation of a Subretinal Vision Prosthesis in Humans

Natural History of Progression of Choroideremia (NIGHT) Study: Cross-Sectional Analysis of Baseline Characteristics

Pathological donor splice site mutations beyond the dinucleotide canonical sequence in choroideremia

A dual variable Markov model to assess the potential benefits of choroideremia gene therapy on quality adjusted life years (QALYs)

To View More...

You must be signed into an individual account to use this feature.